Literature DB >> 22984913

Aging mechanism of soman inhibited acetylcholinesterase.

Gulseher Sarah Sirin1, Yanzi Zhou, Lee Lior-Hoffmann, Shenglong Wang, Yingkai Zhang.   

Abstract

Acetylcholinesterase (n class="Gene">AChE) is a crucial enzyme in the cholinergic nervous system that hydrolyzes neurotransmitter acetylcholine (ACh) and terminates synaptic signals. The catalytic serine of AChE can be phosphonylated by soman, one of the most potent nerve agents, and subsequently undergo an aging reaction. This phosphonylation and aging process leads to irreversible AChE inhibition, results in accumulation of excess ACh at the synaptic clefts, and causes neuromuscular paralysis. By employing Born-Oppenheimer ab initio QM/MM molecular dynamics simulations with umbrella sampling, a state-of-the-art approach to simulate enzyme reactions, we have characterized the aging mechanism of soman phosphonylated AChE and determined its free energy profile. This aging reaction starts with the scission of the O2-Cα bond, which is followed by methyl migration, and results in a tertiary carbenium intermediate. At the transition state, the scissile O2-Cα bond is already cleaved with an average O-C distance of 3.2 ± 0.3 Å and the migrating methyl group is shared between Cα and Cβ carbons with C-C distances of 1.9 ± 0.1 and 1.8 ± 0.1 Å, respectively. The negatively charged phosphonate group is stabilized by a salt bridge with the imidazole ring of the catalytic histidine. A major product of aging, 2,3-dimethyl-2-butanol can be formed swiftly by the reaction of a water molecule. Our characterized mechanism and simulation results provide new detailed insights into this important biochemical process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22984913      PMCID: PMC3475498          DOI: 10.1021/jp307790v

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  56 in total

1.  QM/MM molecular dynamics study of purine-specific nucleoside hydrolase.

Authors:  Ruibo Wu; Wengjin Gong; Ting Liu; Yingkai Zhang; Zexing Cao
Journal:  J Phys Chem B       Date:  2012-02-02       Impact factor: 2.991

2.  Differences in conformational stability between native and phosphorylated acetylcholinesterase as evidenced by a monoclonal antibody.

Authors:  Y Ashani; M K Gentry; B P Doctor
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

3.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

Review 4.  Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology.

Authors:  Israel Silman; Joel L Sussman
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

5.  Ageing and dealkylation of Soman (pinacolylmethylphosphonofluoridate)-inactivated eel cholinesterase.

Authors:  H O Michel; B E Hackley; L Berkowitz; G List; E B Hackley; W Gillilan; M Pankau
Journal:  Arch Biochem Biophys       Date:  1967-07       Impact factor: 4.013

6.  Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.

Authors:  P Masson; P L Fortier; C Albaret; M T Froment; C F Bartels; O Lockridge
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

Review 7.  Chemical warfare. Nerve agent poisoning.

Authors:  C P Holstege; M Kirk; F R Sidell
Journal:  Crit Care Clin       Date:  1997-10       Impact factor: 3.598

8.  Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach.

Authors:  Jeremy Kua; Yingkai Zhang; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2002-07-17       Impact factor: 15.419

9.  Active site cysteine is protonated in the PAD4 Michaelis complex: evidence from Born-Oppenheimer ab initio QM/MM molecular dynamics simulations.

Authors:  Zhihong Ke; Yanzi Zhou; Po Hu; Shenglong Wang; Daiqian Xie; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2009-09-24       Impact factor: 2.991

10.  The role of glutamate-199 in the aging of cholinesterase.

Authors:  A Saxena; B P Doctor; D M Maxwell; D E Lenz; Z Radic; P Taylor
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

View more
  15 in total

1.  Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.

Authors:  Xin Wu; Ramkumar Kuruba; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-08-16       Impact factor: 4.030

2.  A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Eric M Prager; Camila P Almeida-Suhett; James P Apland; Maria F M Braga
Journal:  Toxicol Appl Pharmacol       Date:  2015-02-15       Impact factor: 4.219

3.  The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Volodymyr I Pidoplichko; Taiza H Figueiredo; James P Apland; Jishnu K S Krishnan; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2016-10-31       Impact factor: 4.030

4.  Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Volodymyr I Pidoplichko; Katia Rossetti; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2018-02-21       Impact factor: 4.030

5.  The recovery of acetylcholinesterase activity and the progression of neuropathological and pathophysiological alterations in the rat basolateral amygdala after soman-induced status epilepticus: relation to anxiety-like behavior.

Authors:  Eric M Prager; Vassiliki Aroniadou-Anderjaska; Camila P Almeida-Suhett; Taiza H Figueiredo; James P Apland; Franco Rossetti; Cara H Olsen; Maria F M Braga
Journal:  Neuropharmacology       Date:  2014-01-31       Impact factor: 5.250

6.  DNA cytosine methylation: structural and thermodynamic characterization of the epigenetic marking mechanism.

Authors:  Jin Yang; Lee Lior-Hoffmann; Shenglong Wang; Yingkai Zhang; Suse Broyde
Journal:  Biochemistry       Date:  2013-04-12       Impact factor: 3.162

7.  A fluorogenic aryl fluorosulfate for intraorganellar transthyretin imaging in living cells and in Caenorhabditis elegans.

Authors:  Aleksandra Baranczak; Yu Liu; Stephen Connelly; Wen-Ge Han Du; Erin R Greiner; Joseph C Genereux; R Luke Wiseman; Yvonne S Eisele; Nadine C Bradbury; Jiajia Dong; Louis Noodleman; K Barry Sharpless; Ian A Wilson; Sandra E Encalada; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2015-06-08       Impact factor: 15.419

8.  New therapeutic approaches and novel alternatives for organophosphate toxicity.

Authors:  Francine S Katz; Stevan Pecic; Laura Schneider; Zhengxiang Zhu; Ashley Hastings; Michal Luzac; Joanne Macdonald; Donald W Landry; Milan N Stojanovic
Journal:  Toxicol Lett       Date:  2018-03-31       Impact factor: 4.372

9.  Thiol versus hydroxamate as zinc binding group in HDAC inhibition: An ab initio QM/MM molecular dynamics study.

Authors:  Wenjing Gong; Ruibo Wu; Yingkai Zhang
Journal:  J Comput Chem       Date:  2015-10-09       Impact factor: 3.376

Review 10.  Long-term neuropathological and behavioral impairments after exposure to nerve agents.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Eric M Prager; Volodymyr I Pidoplichko; Steven L Miller; Maria F M Braga
Journal:  Ann N Y Acad Sci       Date:  2016-03-22       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.